BCG Binah Capital Group, Inc.
$1.27▲ +0.48%
Financials
Other
Volume 6.0K
Avg Volume (10D) 36.5K
Key Metrics & Fundamentals
Market Cap
$21.60M
P/E Ratio
12.7
Div Yield
–%
52W Range
1.20 - 3.44
% vs 50 MA
-11.50%
% vs 200 MA
-34.81%
RSI-14
38.2
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.99
Free Cash Flow
$1.10M
Gross Rev
$45.41M
Gross Profit
$4.04M
EBITDA
$1.07M
COGS
$41.37M
Operating Exp
$1.64M
Operating Income
$2.41M
EBIT
$2.41M
Pretax Income
$423,000
Net Income
$337,000
EPS (Diluted)
0.00
Price & Volume History
Loading chart…
Recent News
Sidoti Events, LLC's August Micro-Cap Virtual Conference
ACCESS Newswire · Aug 18, 2026 2:00 PM
Binah Capital Group Reports Results for Second Quarter of 2026
GlobeNewswire · Aug 13, 2026 9:26 PM
Binah Capital Group to Participate in Sidoti Micro-Cap Virtual Conference August 19-20
GlobeNewswire · Aug 12, 2026 12:00 PM
Q&A: Binah CEO Outlines Plans for M&A, Corporate RIA Consolidation
Wealth Management · Jun 24, 2026 9:00 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See BCG's money flow as a full page
Social Sentiment
Avg +0.56 · 10 posts
NewsDDBCG: Hong Kong Overtakes Switzerland as the World’s Top Cross-Border Wealth Booking Center
r/wallstreetbets · Jul 1, 2026
The article highlights BCG's prominence in global wealth management, suggesting a positive outlook for the company.
positive
+0.70
ImmunityBio (IBRX) - moonshot stock?
r/stocks · Jan 20, 2026
The post highlights FDA approval, analyst upgrades, and potential for acquisition, indicating a positive outlook for the stock.
positive
+0.60
NewsDiscussion$IBRX DD — Why I think it has strong potential
r/wallstreetbets · Nov 29, 2025
The post references BCG as a key component of IBRX's approved treatment and its efficacy.
positive
+0.60
DDNewsDiscussion$IBRX DD — Why I think it has strong potential
r/wallstreetbets · Nov 29, 2025
BCG is a component of IBRX's approved treatment, suggesting a connection.
positive
+0.60
NewsDiscussion$IBRX DD — Why I think it has strong potential
r/wallstreetbets · Nov 29, 2025
BCG is a product used with ANKTIVA.
positive
+0.30
Page 1 of 2 (10 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.